Senvera Therapeutics
PrivateTotal Funding Raised
$8M
Company Overview
Senvera Therapeutics is a biotechnology company that develops regenerative therapies targeting the peripheral olfactory stem cell niche to treat conditions such as presbyosmia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
regenerative medicinebiotechnologysmell loss treatmentASOantisense oligonucleotidesolfactory repairpresbyosmiagenetic medicinedrug discoveryotolaryngologybiotech startuptherapeutic pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Senvera Therapeutics Comparables
Compare Senvera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cyrano Therapeutics | 82% | |
| Auration Biotech, Inc. | 59% | |
| Echogenesis Therapeutics | 55% | |
Senvera Therapeutics Funding Rounds
Historical fundraising activity
Senvera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Senvera Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?